BRIEF published on 08/05/2024 at 15:50, 2 years 1 month ago Eckert & Ziegler Expands GalliaPharm® Availability Across EEA Nuclear Medicine GalliaPharm® EEA Approval Radionuclide Generators Cost-effective Diagnostics
BRIEF published on 08/05/2024 at 15:50, 2 years 1 month ago Eckert & Ziegler étend la disponibilité de GalliaPharm® dans l'EEE Médecine Nucléaire GalliaPharm® Approbation EEE Générateurs De Radionucléides Diagnostics Rentables
BRIEF published on 08/05/2024 at 15:48, 2 years 1 month ago The Vanguard Group, Inc. Discloses Position in International Paper Company Form 8.3 Takeover Code Vanguard Group Stock Disclosure International Paper
BRIEF published on 08/05/2024 at 15:48, 2 years 1 month ago The Vanguard Group, Inc. divulgue sa position dans International Paper Company Groupe D'avant-garde Code De Reprise Formulaire 8.3 Papier International Divulgation Des Stocks
BRIEF published on 08/05/2024 at 15:47, 2 years 1 month ago The Vanguard Group, Inc. Reports Position in Balanced Commercial Property Trust Limited Securities Disclosure The Vanguard Group Takeover Code Balanced Commercial Property Trust
BRIEF published on 08/05/2024 at 15:47, 2 years 1 month ago The Vanguard Group, Inc. annonce une position dans Balanced Commercial Property Trust Limited Titres Divulgation Le Groupe Vanguard Code De Reprise Fiducie De Propriété Commerciale Équilibrée
BRIEF published on 08/05/2024 at 15:46, 2 years 1 month ago Vanguard Group Discloses Position in Ascential plc Form 8.3 Takeover Code Vanguard Stock Position Ascential Plc
BRIEF published on 08/05/2024 at 15:46, 2 years 1 month ago Vanguard Group dévoile sa position dans Ascential plc Code De Reprise Formulaire 8.3 Situation Des Stocks Avant-garde Ascension Plc
BRIEF published on 08/05/2024 at 15:45, 2 years 1 month ago The Vanguard Group Discloses Position in Darktrace plc Takeover Code Shareholding Vanguard Stocks Darktrace
BRIEF published on 08/05/2024 at 15:45, 2 years 1 month ago Le groupe Vanguard dévoile sa position dans Darktrace plc Actions Actionnariat Code De Reprise Avant-garde Trace Sombre
Published on 09/11/2026 at 04:00, 7 hours 26 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 1 minute ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 6 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 26 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 1 hour 11 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 2 hours 6 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 20 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 26 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 26 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 26 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 26 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 56 minutes ago Availability of the 2026 Interim Financial Report
